Polysialylated NCAM is highly expressed in many types of cancers, including neuroblastoma, lung cancer, breast cancer, and pancreatic cancer, and its presence is associated with late stage, poorly differentiated, and highly invasive and metastatic disease (2, 23). Here, NCAM1 is linked to pancreatic neoplasm.